CACNA1B c.228C>T ;(p.F76=)

Variant ID: 9-140772613-C-T

NM_000718.3(CACNA1B):c.228C>T;(p.F76=)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer.

Plos One
Janjigian, Yelena Y YY; Vakiani, Efsevia E; Ku, Geoffrey Y GY; Herrera, Jessica M JM; Tang, Laura H LH; Bouvier, Nancy N; Viale, Agnès A; Socci, Nicholas D ND; Capanu, Marinela M; Berger, Michael M; Ilson, David H DH
Publication Date: 2015

Variant appearance in text: CACNA1B: 228C>T; F76F; rs139719558
PubMed Link: 26275293
Variant Present in the following documents:
  • pone.0134731.s005.xls, sheet 1
View BVdb publication page